Class I Recall: MR. 7 Super Capsules Contain Undeclared Sildenafil and Tadalafil

FDA classified a Class I recall of MR. 7 SUPER 700000 capsules distributed by mR. 7 after agency analysis confirmed the presence of undeclared active pharmaceutical ingredients sildenafil and tadalafil. The product was marketed without an approved New Drug Application or Abbreviated New Drug Application. All lot codes with expiration date 12/31/2029 are included in the recall.

Healthcare providers and distributors who received this product should verify their inventories against the recall and follow standard FDA recall procedures. Consumers who have purchased MR. 7 SUPER capsules should discontinue use and contact their healthcare provider if they have experienced any adverse events.